{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:56:12Z","timestamp":1769306172369,"version":"3.49.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"University of Milan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.autrev.2025.103886","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:08:38Z","timestamp":1752937718000},"page":"103886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview"],"prefix":"10.1016","volume":"24","author":[{"given":"Raffaele","family":"Di Taranto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Amati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Crotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Costi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Varenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Beatrice","family":"Chighizola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103886_bb0005","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2025.103886_bb0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/8756-3282(95)00076-P","article-title":"The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix","volume":"16","author":"Landis","year":"1995","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0015","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.3390\/ijms23105725","article-title":"Bone health in children with rheumatic disorders: focus on molecular mechanisms, diagnosis, and management","volume":"23","author":"Di Marcello","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103886_bb0020","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00431-022-04455-2","article-title":"Osteoporosis in children and adolescents: when to suspect and how to diagnose it","volume":"181","author":"Ciancia","year":"2022","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2025.103886_bb0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position","volume":"22","author":"Weber","year":"2019","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0169-6009(92)90712-M","article-title":"Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry","volume":"17","author":"Kr\u00f6ger","year":"1992","journal-title":"Bone Miner"},{"key":"10.1016\/j.autrev.2025.103886_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00247-006-0153-y","article-title":"Pediatric DXA: technique and interpretation","volume":"37","author":"Binkovitz","year":"2007","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry data","volume":"7","author":"Carter","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.autrev.2025.103886_bb0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4103\/ortho.IJOrtho_404_17","article-title":"Femoral neck fractures in children: a review","author":"Palocaren","year":"2018","journal-title":"Indian J Orthop"},{"key":"10.1016\/j.autrev.2025.103886_bb0050","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Osteoporosis III: diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2025.103886_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0060","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","article-title":"In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography","volume":"90","author":"Boutroy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225663","article-title":"HR-pQCT imaging in children, adolescents and young adults: systematic review and subgroup meta-analysis of normative data","volume":"14","author":"Mata-Mbemba","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2025.103886_bb0070","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00330-010-1845-0","article-title":"Radiation exposure in X-ray-based imaging techniques used in osteoporosis","volume":"20","author":"Damilakis","year":"2010","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jocd.2011.05.005","article-title":"Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae","volume":"14","author":"Hans","year":"2011","journal-title":"J Clin Densitom"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0080","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jbmr.499","article-title":"Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study","volume":"26","author":"Hans","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0085","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1515\/jpem-2021-0081","article-title":"Size-adjustment techniques of lumbar spine dual energy X-ray absorptiometry measurements in assessing bone mineralization in children on maintenance hemodialysis","volume":"34","author":"Salem","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jocd.2020.10.008","article-title":"Trabecular bone score in children and adolescents with inflammatory bowel diseases","volume":"24","author":"Levy-Shraga","year":"2021","journal-title":"J Clin Densitom"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0095","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1007\/s00431-023-05157-z","article-title":"Trabecular bone score in assessing bone mineralization status in shildren with snd- stage renal disease: a promising tool","volume":"182","author":"Salem","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0100","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bone.2007.05.012","article-title":"Bone densitometry in the diagnosis of vertebral fractures in children: accuracy of vertebral fracture assessment","volume":"41","author":"M\u00e4yr\u00e4np\u00e4\u00e4","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.autrev.2025.103886_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bone.2017.01.006","article-title":"Vertebral fractures assessment in children: evaluation of DXA imaging versus conventional spine radiography","volume":"97","author":"Crabtree","year":"2017","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-016-0119-z","article-title":"Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids","volume":"14","author":"Harrington","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy x-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0120","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation\u2019s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.autrev.2025.103886_bb0125","first-page":"70","article-title":"Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters","author":"Glastre","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0130","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1359\/jbmr.1999.14.10.1672","article-title":"A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the University of Saskatchewan Bone Mineral Accrual Study","volume":"14","author":"Bailey","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.autrev.2025.103886_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101616","article-title":"Acquisition of peak bone mass","volume":"36","author":"Chevalley","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0140","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbmr.5650100507","article-title":"Peak bone mass in young women","volume":"10","author":"Teegarden","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0145","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1359\/jbmr.2000.15.11.2245","article-title":"Calcium accretion in girls and boys during puberty: a longitudinal analysis","volume":"15","author":"Bailey","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2004-1043","article-title":"Interaction between calcium intake and menarcheal age on bone mass gain: an eight-year follow-up study from prepuberty to postmenarche","volume":"90","author":"Chevalley","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0155","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S0007114509992522","article-title":"Calcium requirements for bone growth in Canadian boys and girls during adolescence","volume":"103","author":"Vatanparast","year":"2010","journal-title":"Br J Nutr"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1359\/jbmr.071006","article-title":"Growth and bone mineral accretion during puberty in Chinese girls: a five-year longitudinal study","volume":"23","author":"Zhu","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0165","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/1529-0131(200007)43:7<1504::AID-ANR13>3.0.CO;2-0","article-title":"Young adults with juvenile arthritis in remission attain normal peak bone mass at the lumbar spine and forearm","volume":"43","author":"Haugen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0170","first-page":"1296","article-title":"Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids","volume":"29","author":"Simon","year":"2002","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0175","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00296-013-2678-3","article-title":"Bone status in adults with early-onset juvenile idiopathic arthritis following 1-year anti-TNF\u03b1 therapy and discontinuation of glucocorticoids","volume":"33","author":"Brabnikova Maresova","year":"2013","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 pediatric position development conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.autrev.2025.103886_bb0190","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00198-012-2030-x","article-title":"Osteoporosis in young adults: pathophysiology, diagnosis, and management","volume":"23","author":"Ferrari","year":"2012","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bone.2007.07.008","article-title":"Osteoporosis in children and adolescents","volume":"41","author":"Bianchi","year":"2007","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0200","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.1780390506","article-title":"Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis","volume":"39","author":"Pepmueller","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0205","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3899\/jrheum.081028","article-title":"Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis","volume":"36","author":"Ringold","year":"2009","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0210","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/art.20282","article-title":"Bone mass in adolescents with early-onset juvenile idiopathic arthritis: comment on the article by Lien et al","volume":"50","author":"Roth","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0215","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/art.22420","article-title":"Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis","volume":"56","author":"Felin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103886_bb0220","first-page":"318","article-title":"Bone health in children and adolescents: risk factors for low bone density","volume":"10","author":"Pitukcheewanont","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0225","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bone.2009.10.003","article-title":"Peak bone mineral density, lean body mass and fractures","volume":"46","author":"Boot","year":"2010","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0230","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1359\/jbmr.060601","article-title":"Association between bone mass and fractures in children: a prospective cohort study","volume":"21","author":"Clark","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.autrev.2025.103886_bb0235","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2005-1404","article-title":"Association between bone density and fractures in children: a systematic review and meta-analysis","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103337","article-title":"A comprehensive overview of juvenile idiopathic arthritis: from pathophysiology to management","volume":"22","author":"Bansal","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-017-0196-7","article-title":"Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-out cohort","volume":"15","author":"Guzman","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3899\/jrheum.130311","article-title":"Effect of biologic treatments on growth in children with juvenile idiopathic arthritis","volume":"41","author":"Uettwiller","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0255","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12969-021-00521-5","article-title":"Growth and puberty in children with juvenile idiopathic arthritis","volume":"19","author":"d\u2019Angelo","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0260","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jpeds.2010.11.020","article-title":"Functional brown adipose tissue is related to muscle volume in children and adolescents","volume":"158","author":"Gilsanz","year":"2011","journal-title":"J Pediatr"},{"issue":"S1","key":"10.1016\/j.autrev.2025.103886_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/1546-0096-6-S1-P45","article-title":"Relationship between delayed menarche and bone density in patients affected by juvenile idiopathic arthritis","volume":"6","author":"Lurati","year":"2008","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0270","first-page":"831","article-title":"Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis","volume":"34","author":"Valta","year":"2007","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0275","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/art.11097","article-title":"Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients","volume":"48","author":"Lien","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0280","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.1780401108","article-title":"Predictors of total body bone mineral density in non-corticosteroid- treated prepubertal children with juvenile rheumatoid arthritis","volume":"40","author":"Henderson","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0285","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/art.20963","article-title":"A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis","volume":"52","author":"Lien","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0169-6009(90)90081-P","article-title":"Bone metabolism in juvenile rheumatoid arthritis","volume":"9","author":"Bianchi","year":"1990","journal-title":"Bone Miner"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0295","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1529-0131(199904)42:4<790::AID-ANR24>3.0.CO;2-G","article-title":"Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study","volume":"42","author":"Zak","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0300","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3899\/jrheum.091241","article-title":"Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients","volume":"37","author":"Stagi","year":"2010","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0305","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-012-2159-1","article-title":"What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence","volume":"32","author":"Nisar","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0310","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12969-018-0250-0","article-title":"Vitamin D and juvenile idiopathic arthritis","volume":"16","author":"Finch","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0315","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3899\/jrheum.131421","article-title":"Determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis","volume":"41","author":"Stagi","year":"2014","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0320","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/nu14081538","article-title":"Vitamin D supplementation in patients with juvenile idiopathic arthritis","volume":"14","author":"Wu","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0325","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.2005.048835","article-title":"Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the general practice research database","volume":"65","author":"Burnham","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0330","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00431-022-04743-x","article-title":"Osteoporosis in children and adolescents: how to treat and monitor?","volume":"182","author":"Ciancia","year":"2023","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.autrev.2025.103886_bb0335","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PEP.0b013e318036a25e","article-title":"Can exercise influence low bone mineral density in children with juvenile rheumatoid arthritis?","volume":"19","author":"Gannotti","year":"2007","journal-title":"Pediatr Phys Ther"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0340","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jbmr.2036","article-title":"Effects of weight-bearing activities on bone mineral content and density in children and adolescents: a meta-analysis","volume":"29","author":"Behringer","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0345","first-page":"929","article-title":"Paediatric rheumatology growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments","volume":"36","author":"Marino","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0350","first-page":"2481","article-title":"Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis","volume":"34","author":"Vojvodich","year":"2007","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0355","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2005.047225","article-title":"Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis","volume":"65","author":"Tynj\u00e4l\u00e4","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s001980050189","article-title":"Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis","volume":"10","author":"Bianchi","year":"1999","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0365","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/keh592","article-title":"Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis","volume":"44","author":"Simonini","year":"2005","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0370","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/keq123","article-title":"Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis","volume":"49","author":"Billiau","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103886_bb0375","article-title":"Insights into the clinical presentation of juvenile systemic lupus erythematosus: the PRAGMA monocentric cohort of 177 patients","volume":"41","author":"Chighizola","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0380","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.autrev.2018.01.004","article-title":"Vitamin D and juvenile systemic lupus erythematosus: lights, shadows and still unresolved issues","volume":"17","author":"Stagi","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0385","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/annrheumdis-2011-200106","article-title":"A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus","volume":"71","author":"Rygg","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101893","article-title":"Systemic lupus erythematosus and damage: what has changed over the past 20 years?","volume":"37","author":"Mu\u00f1oz-Grajales","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0395","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/art.22691","article-title":"Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus","volume":"56","author":"Compeyrot-Lacassagne","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0400","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/0961203308089446","article-title":"The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus","volume":"17","author":"Regio","year":"2008","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0405","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1177\/0961203314532564","article-title":"Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study","volume":"23","author":"Stagi","year":"2014","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0410","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bone.2004.06.009","article-title":"The relationship between lean body mass and bone mineral content in paediatric health and disease","volume":"35","author":"Crabtree","year":"2004","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0415","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1177\/0961203319869467","article-title":"Risk factors for bone loss in juvenile-onset systemic lupus erythematosus: a prospective study","volume":"28","author":"de Sousa","year":"2019","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0420","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6065\/apem.2346060.030","article-title":"Factors affecting bone mineral density in children and adolescents with systemic lupus erythematosus","volume":"29","author":"Park","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0425","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00198-015-3461-y","article-title":"Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus","volume":"27","author":"Paupitz","year":"2019","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0430","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/acr.21684","article-title":"Exercise training in juvenile dermatomyositis","volume":"64","author":"Omori","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0435","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11914-014-0228-x","article-title":"Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment","volume":"12","author":"von Scheven","year":"2014","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0440","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.11211","article-title":"Bone mineral density in juvenile dermatomyositis: assessment using dual x-ray absorptiometry","volume":"48","author":"Stewart","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0445","first-page":"782","article-title":"Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients","volume":"28","author":"Mathiesen","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0450","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.autrev.2025.103886_bb0455","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","article-title":"Glucocorticoids and bone: local effects and systemic implications","volume":"25","author":"Henneicke","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0460","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.autrev.2025.103886_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semarthrit.2014.02.002","article-title":"A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children","volume":"44","author":"Hansen","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0470","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002960050056","article-title":"Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density","volume":"18","author":"Trapani","year":"1998","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0475","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0480","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3899\/jrheum.110305","article-title":"Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis","volume":"39","author":"Markula-Patjas","year":"2012","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0485","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0490","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpeds.2008.09.023","article-title":"Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia","volume":"154","author":"Nakhla","year":"2009","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0495","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/acr.20171","article-title":"Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0500","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/jbmr.2511","article-title":"Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders","volume":"30","author":"LeBlanc","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0505","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J Mol Med"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0510","doi-asserted-by":"crossref","first-page":"297","DOI":"10.18388\/abp.2017_2561","article-title":"Is it possible to predict a risk of osteoporosis in patients with juvenile idiopathic arthritis? A study of serum levels of bone turnover markers","volume":"65","author":"Janicka-Szczepaniak","year":"2018","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.autrev.2025.103886_bb0515","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1546-0096-8-30","article-title":"Serum levels of osteoprotegerin and receptor activator of nuclear factor -\u03baB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study","volume":"8","author":"Lien","year":"2010","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0520","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/03009740802116224","article-title":"Osteoprotegerin\/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?","volume":"37","author":"Spelling","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"16","key":"10.1016\/j.autrev.2025.103886_bb0525","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0530","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","article-title":"Sclerostin levels during growth in children","volume":"23","author":"Kirmani","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0535","article-title":"Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis","volume":"16","author":"Brabnikova-Maresova","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0540","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41390-023-02637-8","article-title":"The plasma levels of Dickkopf-1 elevated in patients with juvenile idiopathic arthritis","volume":"94","author":"Ye","year":"2023","journal-title":"Pediatr Res"},{"key":"10.1016\/j.autrev.2025.103886_bb0545","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0550","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3476(05)82424-2","article-title":"25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density","volume":"119","author":"Reed","year":"1991","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0555","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/art.24041","article-title":"Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: results of a double-blind, placebo-controlled intervention trial","volume":"58","author":"Carrasco","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103886_bb0560","first-page":"4921","article-title":"Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: an open-label, prospective, randomized controlled trial","volume":"18","author":"Tang","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.autrev.2025.103886_bb0565","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.c7254","article-title":"Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis","volume":"342","author":"Winzenberg","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0570","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11926-010-0161-7","article-title":"Vitamin D supplementation in the pediatric rheumatology clinic","volume":"13","author":"Von Scheven","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0575","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00467-005-2118-z","article-title":"Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome","volume":"21","author":"Bak","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0580","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-015-0017-9","article-title":"Vitamin D-update for the pediatric rheumatologists","volume":"13","author":"Vojinovic","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0585","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1079\/BJN20041118","article-title":"School-milk intervention trial enhances growth and bone mineral accretion in Chinese girls aged 10\u201312 years in Beijing","volume":"92","author":"Du","year":"2004","journal-title":"Br J Nutr"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0590","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/art.21956","article-title":"A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis","volume":"54","author":"Lovell","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0595","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study","volume":"43","author":"Bianchi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0600","first-page":"1786","article-title":"Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases","volume":"29","author":"Cimaz","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103886_bb0605","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1756-185X.12560","article-title":"Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review","volume":"18","author":"Jayasena","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0610","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/JPEM.2003.16.4.529","article-title":"Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children","volume":"16","author":"Noguera","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0615","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/rheumatology\/keh538","article-title":"Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment","volume":"44","author":"Rudge","year":"2005","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0620","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10067-008-0864-6","article-title":"Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases","volume":"27","author":"Inoue","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0625","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-018-0258-5","article-title":"Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study","volume":"16","author":"Inoue","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.autrev.2025.103886_bb0630","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eclinm.2019.06.004","article-title":"The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: a randomised double-blind controlled trial","volume":"12","author":"Rooney","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.autrev.2025.103886_bb0635","first-page":"13","article-title":"Efficacy and safety of bisphosphonates on childhood osteoporosis secondary to chronic illness or its treatment: a meta-analysis","author":"Zhao","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0640","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/acr.20589","article-title":"Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study","volume":"64","author":"Rodd","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2025.103886_bb0645","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00467-004-1790-8","article-title":"Pamidronate treatment of pediatric fracture patients on chronic steroid therapy","volume":"20","author":"Acott","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0650","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/archdischild-2023-326287","article-title":"Severity of acute phase reaction in children receiving the first dose of zoledronic acid and the impact of the underlying condition: a cross-sectional study","volume":"109","author":"Nayak","year":"2024","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.autrev.2025.103886_bb0655","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000365889","article-title":"The use of bisphosphonates in pediatrics","volume":"82","author":"Baroncelli","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0660","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00198-019-05227-9","article-title":"Intravenous bisphosphonate therapy in children with spinal muscular atrophy","volume":"31","author":"Nasomyont","year":"2020","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0665","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jpc.13768","article-title":"Consensus guidelines on the use of bisphosphonate therapy in children and adolescents","volume":"54","author":"Simm","year":"2018","journal-title":"J Paediatr Child Health"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0670","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/jc.2015-2680","article-title":"Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience","volume":"100","author":"George","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2025.103886_bb0675","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bone.2019.01.003","article-title":"Outcomes following intravenous bisphosphonate infusion in pediatric patients: a 7-year retrospective chart review","volume":"121","author":"Nasomyont","year":"2019","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0680","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2106\/00004623-200707000-00015","article-title":"Zebra lines of pamidronate therapy in children","volume":"89","author":"Al Muderis","year":"2007","journal-title":"J Bone Joint Surg"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0685","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bone.2005.02.016","article-title":"Quantification of metaphyseal modeling in children treated with bisphosphonates","volume":"36","author":"Ward","year":"2005","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0690","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00223-020-00707-1","article-title":"Bisphosphonate therapy and tooth development in children and adolescents with osteogenesis imperfecta","volume":"107","author":"Malmgren","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.autrev.2025.103886_bb0695","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.004","article-title":"Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment","volume":"94","author":"Vuorimies","year":"2017","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0700","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00223-010-9366-z","article-title":"Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats","volume":"86","author":"Hiraga","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.autrev.2025.103886_bb0705","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jdsr.2022.03.001","article-title":"Management of bisphosphonate preparation-treated children in the field of pediatric dentistry","volume":"58","author":"Mitsuhata","year":"2022","journal-title":"Jpn Dent Sci Rev"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0710","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.joms.2022.06.026","article-title":"Medication-related osteonecrosis of the jaws in the pediatric population","volume":"80","author":"Neal","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0715","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.joms.2024.06.162","article-title":"The risk of medication-related osteonecrosis of the jaw in children: guidance for antiresorptive use in pediatric patients","volume":"82","author":"Lasky","year":"2024","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Supplement","key":"10.1016\/j.autrev.2025.103886_bb0720","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0725","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0730","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000447425","article-title":"A subtrochanteric femoral stress fracture following bisphosphonate. Treatment in an adolescent girl","volume":"87","author":"Boyce","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.autrev.2025.103886_bb0735","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2016.07.022","article-title":"Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation","volume":"91","author":"van de Laarschot","year":"2016","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0740","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jbmr.2805","article-title":"Recurrent proximal femur fractures in a teenager with osteogenesis imperfecta on continuous bisphosphonate therapy: are we overtreating?","volume":"31","author":"Vasanwala","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0745","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jbmr.3071","article-title":"Diaphyseal femur fractures in osteogenesis imperfecta: characteristics and relationship with bisphosphonate treatment","volume":"32","author":"Trejo","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0750","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/ans.12536","article-title":"Delayed\/non-union of upper limb fractures with bisphosphonates: systematic review and recommendations","volume":"84","author":"Ng","year":"2014","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0755","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0760","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41584-023-00935-3","article-title":"Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone","volume":"19","author":"Ferrari","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0765","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/clinem\/dgad732","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfecta\u2014the first prospective comparative study","volume":"109","author":"Liu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0770","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13023-019-1197-z","article-title":"Individualized treatment with denosumab in children with osteogenesis imperfecta \u2013 follow up of a trial cohort","volume":"14","author":"Hoyer-Kuhn","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0775","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/clinem\/dgad657","article-title":"Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document","volume":"109","author":"Vanderniet","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2025.103886_bb0780","doi-asserted-by":"crossref","first-page":"470","DOI":"10.21037\/tp-22-276","article-title":"Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review","volume":"12","author":"Wang","year":"2023","journal-title":"Transl Pediatr"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0785","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00467-024-06288-7","article-title":"Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to pneumocystis jirovecii pneumonia","volume":"39","author":"Beale","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0790","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00198-021-06002-5","article-title":"Denosumab for the treatment of primary pediatric osteoporosis","volume":"32","author":"Anastasilakis","year":"2021","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0795","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40618-021-01630-4","article-title":"Mechanisms of acute hypercalcemia in pediatric patients following the interruption of Denosumab","volume":"45","author":"Deodati","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0800","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s12519-020-00378-w","article-title":"Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?","volume":"16","author":"Sydlik","year":"2020","journal-title":"World J Pediatr"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0805","article-title":"Denosumab-induced rebound hypercalcemia treated with bisphosphonates in a pediatric patient","volume":"1","author":"Gandolfi","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0810","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/jc.2017-02025","article-title":"Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumor of bone","volume":"103","author":"Uday","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0815","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1007\/s00247-024-05895-8","article-title":"Denosumab-induced bone changes in a child: a case report","volume":"54","author":"Rutten","year":"2024","journal-title":"Pediatr Radiol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0820","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle John","year":"2002","journal-title":"Toxicol Pathol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0825","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10665","article-title":"Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates","volume":"6","author":"Krege","year":"2022","journal-title":"JBMR Plus"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2025.103886_bb0830","first-page":"53","article-title":"Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism","volume":"27","author":"Matarazzo","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0835","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12020-019-02128-z","article-title":"Teriparatide (rhPTH 1\u201334) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism","volume":"67","author":"Tuli","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2025.103886_bb0840","first-page":"9","article-title":"Intermittent bi-daily sub-cutaneous teriparatide administration in children with hypoparathyroidism: a single-center experience","author":"Bernardor","year":"2021","journal-title":"Front Pediatr"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0845","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00198-020-05549-z","article-title":"Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy","volume":"31","author":"Nasomyont","year":"2020","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0850","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-020-0411-9","article-title":"Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children","volume":"18","author":"Galindo-Zavala","year":"2020","journal-title":"Pediatr Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0855","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.42646","article-title":"2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2025.103886_bb0860","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/ard.50.9.602","article-title":"Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis","volume":"50","author":"Allen","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0865","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009749709115826","article-title":"Growth retardation in non-steroid treated juvenile rheumatoid arthritis","volume":"26","author":"Polito","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0870","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1651-2227.1999.tb00032.x","article-title":"Growth of prepubertal children with juvenile chronic arthritis","volume":"88","author":"Saha","year":"1999","journal-title":"Acta Paediatr"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0875","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100670200098","article-title":"Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment","volume":"21","author":"Wang","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2025.103886_bb0880","first-page":"2481","article-title":"Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis","volume":"34","author":"Fernandez Vojvodich","year":"2007","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103886_bb0885","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.2007-0544","article-title":"Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study","volume":"92","author":"Bechtold","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0890","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.3899\/jrheum.080199","article-title":"Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis","volume":"35","author":"Souza","year":"2008","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103886_bb0895","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/art.27682","article-title":"Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis","volume":"62","author":"Giannini","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0900","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2011.04.012","article-title":"Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation","volume":"159","author":"Padeh","year":"2011","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.autrev.2025.103886_bb0905","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/keu489","article-title":"Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"54","author":"Kearsley-Fleet","year":"2015","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semarthrit.2017.11.002","article-title":"Growth patterns in early juvenile idiopathic arthritis: results from the childhood arthritis prospective study (CAPS)","volume":"48","author":"McErlane","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0915","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1542\/peds.91.6.1127","article-title":"Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids","volume":"91","author":"Kotaniemi","year":"1993","journal-title":"Pediatrics"},{"issue":"5 Pt 1","key":"10.1016\/j.autrev.2025.103886_bb0920","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-3476(06)80006-5","article-title":"Repair of osteopenia in children juvenile rheumatoid arthritis with","volume":"122","author":"Reed","year":"1993","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.autrev.2025.103886_bb0925","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-3476(05)83179-8","article-title":"Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis","volume":"124","author":"Hillman","year":"1994","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0930","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.54.3.193","article-title":"Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis","volume":"54","author":"Polito","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0935","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03349860","article-title":"The primary role of steroids on the osteoporosis in juvenile rheumatoid arthritis patients evaluated by dual energy X-ray absorptiometry","volume":"19","author":"Falcini","year":"1996","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb0940","first-page":"1065","article-title":"Osteopenia in adults with a history of juvenile rheumatoid arthritis. A population based study","volume":"29","author":"French","year":"2002","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0945","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00296-002-0265-0","article-title":"Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis","volume":"23","author":"\u00c7eliker","year":"2003","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0950","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/03009740903337885","article-title":"Bone mineral content in young adults with active or inactive juvenile idiopathic arthritis and in controls","volume":"39","author":"H\u00e4m\u00e4l\u00e4inen","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb0955","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-024-00982-4","article-title":"Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study","volume":"22","author":"Vasil","year":"2024","journal-title":"Pediatr Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103886_bb0960","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02555248","article-title":"Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy","volume":"41","author":"Varonos","year":"1987","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0965","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.4103\/jfmpc.jfmpc_480_24","article-title":"Pattern of physical growth and pubertal changes in adolescent girls with systemic lupus erthythematosus","volume":"13","author":"Nori","year":"2024","journal-title":"J Family Med Prim Care"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0970","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1590\/S0100-879X2002001000008","article-title":"Bone mineral density in juvenile systemic lupus erythematosus","volume":"35","author":"Castro","year":"2002","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb0975","first-page":"729","article-title":"Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise","volume":"32","author":"Alsufyani","year":"2005","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb0980","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/annrheumdis-2011-200805","article-title":"Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients","volume":"71","author":"Lim","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.autrev.2025.103886_bb0985","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1177\/0961203314543916","article-title":"Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA)","volume":"23","author":"Stagi","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103886_bb0990","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0100-879X2005000200020","article-title":"Bone mineral density of girls with juvenile dermatomyositis","volume":"38","author":"De Castro","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.autrev.2025.103886_bb0995","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.22433","article-title":"RANKL: Osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis","volume":"56","author":"Rouster-Stevens","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2025.103886_bb1000","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03009740701687226","article-title":"Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use","volume":"37","author":"Santiago","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103886_bb1005","first-page":"986","article-title":"Osteoprotegerin (OPG)\/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG\/RANK-L in bone injury?","volume":"31","author":"Masi","year":"2004","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103886_bb1010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejr.2011.08.001","article-title":"Early predictors of increased bone resorption in juvenile idiopathic arthritis: OPG\/RANKL ratio, as a key regulator of bone metabolism","volume":"33","author":"Alkady","year":"2011","journal-title":"Egypt Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103886_bb1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: an update","volume":"23","author":"Arnaud","year":"2024","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:54:32Z","timestamp":1763769272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":203,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1568997225001466"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103886","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103886"}}